Santen Pharmaceutical , Ltd. Intangible Assets

Santen Pharmaceutical , Ltd. (SNPHF) currently reports a intangible assets of $72B as of June 2026. That compares with $74B in the prior-year period — down 2.6% year over year. Use the charts on this page to explore Santen Pharmaceutical , Ltd.'s intangible assets history and peer comparisons.

Santen Pharmaceutical , Ltd.'s intangible assets decreased from $74B to $72B — a 2.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Santen Pharmaceutical , Ltd. reported $72B in intangible assets as of June 2026. That compares with $74B in the prior-year period — down 2.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $72B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Santen Pharmaceutical , Ltd., and consider following SNPHF for alerts when major investors trade the stock.